Statistics
Publications
6
Citations
1.4K
H-Index
6
Active since
2018
Emily Robitschek is an author at Dana-Farber Cancer Institute specializing in medicine, cancer immunotherapy, and tumor immunology.
Publications per year
2018–2025
6
6
Loss of ADAR1 in tumours overcomes resistance to immune checkpoint blockade
Jeffrey J. Ishizuka, Robert T. Manguso, Collins Cheruiyot et al. · Nature · 2018 · 715 citations · Full text
Medicine, Cancer Biology, Oncology +14
Epigenetic silencing by SETDB1 suppresses tumour intrinsic immunogenicity
Gabriel K. Griffin, Jingyi Wu, Arvin Iracheta‐Vellve et al. · Nature · 2021 · 362 citations · Full text
Targeting TBK1 to overcome resistance to cancer immunotherapy
Yi Sun, Or‐Yam Revach, Seth Anderson et al. · Nature · 2023 · 167 citations · Full text
Medicine, Cancer Biology, Oncology +12
Evolution of delayed resistance to immunotherapy in a melanoma responder
David Liu, Jia‐Ren Lin, Emily Robitschek et al. · Nature Medicine · 2021 · 134 citations · Full text
Medicine, Immunology, Oncology +14
1–5 of 6